The Office of Technology Development manages Memorial Sloan Kettering’s world-class portfolio of intellectual property. We are responsible for:
- Identifying and evaluating new inventions
- Seeking patent protection
- Developing, managing, and commercializing the institution’s innovations
- Facilitating start-up creation.
The goal of our technology transfer activities is to ensure that scientific research at Memorial Sloan Kettering is developed and applied for the common good.
Tri-Institutional Therapeutics Discovery Institute
The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) is a unique partnership among Weill Cornell Medical College, Memorial Sloan Kettering and Rockefeller University. Tri-I TDI has entered into an initial partnership with Takeda Pharmaceuticals to assist academic investigators at the three institutions to develop small molecule therapeutic agents and molecular probes.
Learn more about the partnership »
For MSK Investigators
View the Office of Technology Development's Intranet page.